Twist Bioscience (TWST) Free Cash Flow (2017 - 2026)

Twist Bioscience (TWST) has reported Free Cash Flow for 10 consecutive years, with -$21.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Free Cash Flow fell 81.93% year-over-year to -$21.9 million; the TTM figure through Mar 2026 stood at -$61.4 million (down 7.73% YoY), while the FY2025 annual figure was -$49.2 million, up 22.72% from the prior year.
• Free Cash Flow climbed to -$21.9 million in Q1 2026 per TWST's latest filing, from -$26.0 million in the prior quarter.
• Across five years, Free Cash Flow topped out at -$674000.0 in Q2 2025 and bottomed at -$90.3 million in Q1 2022.
• Historically, Free Cash Flow has averaged -$30.2 million across 5 years, with a median of -$22.7 million in 2023.
• Annual changes were most pronounced in 2022 — Free Cash Flow plunged 265.76% — and 2025, when it jumped 92.83%.
• Twist Bioscience's Free Cash Flow stood at -$65.9 million in 2022, then soared by 65.59% to -$22.7 million in 2023, then declined by 4.51% to -$23.7 million in 2024, then slipped by 9.71% to -$26.0 million in 2025, then increased by 15.69% to -$21.9 million in 2026.
• Business Quant data shows TWST's Free Cash Flow at -$21.9 million in Q1 2026, -$26.0 million in Q4 2025, and -$12.8 million in Q3 2025.